Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 16, 2026

Daily SignalsNeutral

2759 companies scored · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run
Companies scored 2759 IC ≥ 0 · market cap ≥ $100M
Median forecast -0.41% Alpha · 90D
Long–short spread +5.11% Strong Buy minus Strong Sell, mean
Median IC 0.27 Spearman · 90D
Rating changes ▲ 290 ▼ 470 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

52 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 ACBAURORA CANNABIS INC Life Sciences 0.16 $253M Neutral +0.07% +0.17% ·
2 SMMTSummit Therapeutics Inc. Life Sciences 0.32 $11.7B Neutral +0.05% +0.13% ·
3 KROSKeros Therapeutics, Inc. Life Sciences 0.15 $211M Neutral +0.03% +0.09% ·
4 INSMINSMED Inc Life Sciences 0.43 $21.0B Neutral +0.01% +0.04% ·
5 QGENQIAGEN N.V. Life Sciences 0.18 $10.0B Neutral +0.01% +0.04% ·
6 BBIOBridgeBio Pharma, Inc. Life Sciences 0.08 $13.0B Neutral -0.01% +0.02% ·
7 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.31 $13.8B Neutral -0.02% 0.00% ·
8 HCMHUTCHMED (China) Ltd Life Sciences 0.14 $2.5B Neutral -0.02% 0.00% ·
9 NRIXNurix Therapeutics, Inc. Life Sciences 0.27 $2.5B Neutral -0.02% -0.01% ·
10 SABSSAB Biotherapeutics, Inc. Life Sciences 0.15 $230M Neutral -0.03% -0.02% ·
11 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.56 $31.0B Neutral -0.04% -0.04% ·
12 COGTCogent Biosciences, Inc. Life Sciences 0.20 $5.1B Neutral -0.05% -0.05% ·
13 RIGLRIGEL PHARMACEUTICALS INC Life Sciences 0.05 $859M Neutral -0.06% -0.08% ·
14 BHCBausch Health Companies Inc. Life Sciences 0.51 $2.4B Neutral -0.08% -0.12% ·
15 VTVTvTv Therapeutics Inc. Life Sciences 0.14 $342M Neutral -0.08% -0.13% ▼ 1
16 CYRXCryoport, Inc. Life Sciences 0.29 $853M Neutral -0.09% -0.14% ·
17 IRWDIRONWOOD PHARMACEUTICALS INC Life Sciences 0.22 $578M Neutral -0.13% -0.22% ▲ 1
18 FTHFaeth Therapeutics, Inc. Life Sciences 0.07 $486M Neutral -0.14% -0.23% ·
19 RPRXRoyalty Pharma plc Life Sciences 0.28 $26.9B Neutral -0.13% -0.23% ▼ 1
20 PCRXPacira BioSciences, Inc. Life Sciences 0.27 $1.4B Neutral -0.14% -0.25% ·
21 KRYSKrystal Biotech, Inc. Life Sciences 0.18 $9.4B Neutral -0.16% -0.28% ·
22 KRSAKorsana Biosciences, Inc. Life Sciences 0.15 $1.5B Neutral -0.16% -0.29% ·
23 BMRNBIOMARIN PHARMACEUTICAL INC Life Sciences 0.31 $10.6B Neutral -0.19% -0.34% ·
24 UTHRUNITED THERAPEUTICS Corp Life Sciences 0.01 $22.9B Neutral -0.20% -0.37% ▲ 1
25 ARDXARDELYX, INC. Life Sciences 0.39 $770M Neutral -0.21% -0.39% ·
26 LKFTLakefront Biotherapeutics NV Life Sciences 0.38 $2.0B Neutral -0.22% -0.40% ·
27 NBPNovaBridge Biosciences Life Sciences 0.18 $145M Neutral -0.23% -0.44% ·
28 INVAInnoviva, Inc. Life Sciences 0.07 $1.5B Neutral -0.24% -0.45% ·
29 VRDNViridian Therapeutics, Inc.\DE Life Sciences 0.46 $2.2B Neutral -0.24% -0.45% ▼ 1
30 LLYELI LILLY & Co Life Sciences 0.23 $1.2T Neutral -0.24% -0.46% ·
31 ABBVAbbVie Inc. Life Sciences 0.01 $504.5B Neutral -0.25% -0.48% ·
32 VRTXVERTEX PHARMACEUTICALS INC / MA Life Sciences 0.14 $126.7B Neutral -0.26% -0.49% ▲ 1
33 BMYBRISTOL MYERS SQUIBB CO Life Sciences 0.43 $122.1B Neutral -0.26% -0.51% ·
34 MGTXMeiraGTx Holdings plc Life Sciences 0.31 $891M Neutral -0.27% -0.53% ·
35 NAGENiagen Bioscience, Inc. Life Sciences 0.59 $197M Neutral -0.28% -0.55% ·
36 AMPHAmphastar Pharmaceuticals, Inc. Life Sciences 0.40 $1.1B Neutral -0.30% -0.60% ·
37 LEGNLegend Biotech Corp Life Sciences 0.03 $3.4B Neutral -0.31% -0.61% ·
38 REGNREGENERON PHARMACEUTICALS, INC. Life Sciences 0.24 $81.8B Neutral -0.31% -0.63% ·
39 VCELVericel Corp Life Sciences 0.40 $2.1B Neutral -0.32% -0.64% ▼ 1
40 COAGHemab Therapeutics Holdings, Inc. Life Sciences 0.46 $1.4B Neutral -0.33% -0.67% ·
41 CGENCOMPUGEN LTD Life Sciences 0.31 $197M Neutral -0.34% -0.68% ·
42 CRMDCorMedix Inc. Life Sciences 0.18 $566M Neutral -0.34% -0.69% ·
43 DBVTDBV Technologies S.A. Life Sciences 0.35 $536M Neutral -0.34% -0.70% ·
44 AUPHAurinia Pharmaceuticals Inc. Life Sciences 0.11 $2.2B Neutral -0.35% -0.73% ·
45 PFEPFIZER INC Life Sciences 0.26 $168.6B Neutral -0.36% -0.74% ▲ 1
46 MDWDMediWound Ltd. Life Sciences 0.29 $157M Neutral -0.37% -0.77% ·
47 INDVIndivior Pharmaceuticals, Inc. Life Sciences 0.52 $3.8B Neutral -0.37% -0.79% ▲ 1
48 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.30 $242M Neutral -0.38% -0.81% ·
49 LGNDLIGAND PHARMACEUTICALS INC Life Sciences 0.02 $5.9B Neutral -0.40% -0.86% ·
50 COLLCOLLEGIUM PHARMACEUTICAL, INC Life Sciences 0.63 $755M Neutral -0.42% -0.91% ▲ 1
1–50 of 52 Previous Next
Since the previous run

Rating changes

▲ 290▼ 470
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.